Twenty High-Potential Startups Selected for MedTech Innovator’s 2025 Asia Pacific Accelerator

Top medtech innovators from nine countries selected to join region’s leading commercialization platform and compete for USD 300,000 in non-dilutive cash prizes and awards

LOS ANGELES & SINGAPORE--(BUSINESS WIRE)--MedTech Innovator, the world’s largest accelerator of medical technology companies, today announced that 20 high-potential medtech companies will participate in the sixth annual Asia Pacific (APAC) Accelerator program.

“We’re incredibly proud to welcome this diverse and dynamic group of startups to the 2025 Asia Pacific Accelerator Program,” said Fredrik Nyberg, managing director, MedTech Innovator Asia Pacific. “This year’s cohort is tackling some of the most pressing challenges in healthcare with bold ideas and transformative technologies. We’re excited to support their journey, connect them with key industry partners, and accelerate their path to market, ultimately improving patient outcomes across APAC and globally.”

MedTech Innovator Asia Pacific unites best-in-class startups with investors, business leaders, and allied service professionals in the medtech industry to help drive the commercialization of life-changing technologies in the region. The 2025 cohort companies will also compete for up to USD 300,000 in non-dilutive cash prizes and awards.

More than 550 companies applied for the Asia Pacific program this year, and after a rigorous selection process, 60 companies were invited to pitch, 20 of which were named to the 2025 cohort. The Asia Pacific Accelerator 2025 Cohort will attend the program’s kick-off, joining the MedTech Innovator and the BioTools Innovator 2025 Cohorts at the invitation-only Innovator Summit on June 25-26 in Mountain View, California. This event connects the leadership teams from the latest cohorts with MedTech Innovator’s partners, alumni, and other industry leaders.

The 20 companies selected for the 2025 MedTech Innovator Asia Pacific Accelerator are:

• 2Strands Biosciences, Singapore
• Australis Scientific, Brisbane, Australia
• Belun Technology, Singapore
• B dot Medical, Tokyo, Japan
• Borns Medical Robotics Inc., San Jose, California, United States
• ClearCut Medical, Rehovot, Israel
• F.MED, Fukuoka, Japan
• Hemotag, Boca Raton, Florida, United States
• Heuron Co., Seoul, South Korea
• HiCura Medical, Singapore
• Laronix, Brisbane, Australia
• MAXM Skate, Adelaide, Australia
• MEDICAL IP, Seoul, South Korea
• MedInTech Inc., Seoul, South Korea
• OsseoLabs, Bangkok, Thailand
• Pretect Devices, Perth, Australia
• Rosalind Dx, Singapore
• Sehat Kahani, Karachi, Pakistan
• SIMPLEX QUANTUM, Tokyo, Japan
• VesselSens, Bonn, Germany

MedTech Innovator Asia Pacific’s 2025 program sponsors include Johnson & Johnson MedTech, B. Braun Medical, Becton Dickinson, Teleflex, Siemens Healthineers, Cambridge Consultants, and Enterprise Singapore. The program will culminate with its first-ever self-hosted Showcase and Grand Finals in Singapore at the end of October.

About MedTech Innovator

MedTech Innovator is the world’s largest accelerator of medical technology companies. Its mission is to improve human health by accelerating the growth of companies that are transforming care. MedTech Innovator has been a catalyst for groundbreaking healthcare solutions, reviewing well over 14,000 applicants and fostering the growth of 717 companies globally that have collectively raised over USD 9.5 billion in follow-on funding, transforming the lives of millions.

For more information about MedTech Innovator Asia Pacific, its annual programs, portfolio of industry-leading startups, and insights on trends, visit MedTech Innovator Asia Pacific’s website, follow the U.S. organization on LinkedIn U.S. and its APAC program at LinkedIn APAC, and subscribe to its monthly newsletter.